Abzena

Abzena is a leading biopharmaceutical CDMO and CRO specializing in complex biologics and bioconjugates, offering fully integrated drug design, development, and GMP manufacturing services that span from discovery to commercial stages. With over 20 years of expertise, the company is dedicated to simplifying and securing supply chains while enabling the delivery of life-changing medicines to patients in need.

Focused on innovation and quality, Abzena provides a comprehensive range of services including antibody discovery, bioconjugate development, and analytical solutions, all underpinned by robust capabilities and personalized customer experiences. Their state-of-the-art facilities support a wide array of biologic modalities, ensuring effective and accelerated timelines for bringing drugs to market.

Generated from the website